CD4 and rheumatoid arthritis: EVs derived from IFN-β-primed MSCs were more effective than naïve MSC-EVs or MSCs alone in suppressing key RA-associated cytokines, reducing CD4+ T-cell polyfunctionality, and restoring T-regulatory cell frequency.